In Vitro ADC Testing
ADC Functional Testing Platform
This ADC platform is an in vitro testing service that evaluates target engagement, internalization, and cytotoxic activity of antibody-drug conjugate candidates in cell-based assays.
Five assay groups
- 1Binding Activity
- 2Cross-Species and Knockout Validation
- 3Internalization
- 4Bystander Effect
- 5Cytotoxicity
Service Overview
In Vitro ADC Functional Testing Overview
The development of Antibody-Drug Conjugates (ADCs) is a complex engineering process. We have established a comprehensive in vitro functional testing platform covering the entire Mechanism of Action (MOA)—from protein binding and cellular recognition to internalization efficiency and final cytotoxic effects —providing precise data for candidate screening and optimization.
Binding Activity
Evaluation of ADC Binding Activity
Binding is the first step for ADCs to exert targeted therapy.
Protein-Level Binding by ELISA
Quantitatively measure the affinity and specificity between ADCs and purified antigen proteins using high-throughput, high-sensitivity ELISA.
Cell-Level Binding by Flow Cytometry
Evaluate binding capacity in the native cellular membrane environment using Flow Cytometry (FACS) for a more realistic reflection of biological recognition.
Specificity
Cross-Species Reactivity and Preliminary Off-Target Validation
Two cell-engineering approaches address species relevance and target dependence, supporting antibody-drug conjugate testing before animal studies are planned.
Multi-Species Cell Models
We construct cell lines expressing target antigens from various species (e.g., human, monkey, mouse) to assess cross-species reactivity, providing a scientific basis for selecting animal toxicology models.
Knockout Validation (Preliminary Off-Target)
Utilizing advanced gene editing we construct Target Knockout (KO) cell lines. By comparing binding and killing differences between Wild-Type (WT) and KO cells, we verify target specificity and rule out non-specific off-target risks.
Internalization
Comprehensive Internalization Assays
Internalization is the key step for ADCS to deliver the payload.
Stripping Assay
Precisely distinguish and quantify internalized ADCs by stripping un-internalized antibodies from the cell surface using acidic buffers.
pHrodo-Based Internalization Assay
Label ADCs with pH-sensitive dyes. Fluorescence intensifies in the acidic environment of endosomes/lysosomes. We offer both Flow Cytometry (quantitative and Live-Cell Imaging (visualization) modes.
DT3C Enzymatic Reporter Assay
A wash-free method with high signal-to-noise ratio. The DT3C enzyme is released upon lysosomal degradation of the ADC, generating a fluorescent signal.
Bystander Effect
Bystander Effect Evaluation
To address tumor heterogeneity, we simulate the in vivo tumor microenvironment using co-cultures if Antigen-Positive (Ag+) and Antigen-Negative (Ag-) cells (fluorescently labeled). This assay precisely quantifies the killing ability of the payload on Ag- cells, evaluating linker stability and membrane permeability.
Cytotoxicity
Cytotoxicity Evaluation
To verify the antitumor activity and efficacy of the drug payload, we evaluate the in vitro cytotoxic performance of the agent via mono-culture of tumor cells. This assay accurately detects, assessing the overall antitumor potency, drug bioactivity and effective cell killing efficiency of the conjugate.
Why Kyinno
Why Work With Kyinno
The service pairs a defined set of functional assays with in-house cell engineering.
- Five assay groups cover binding, specificity, internalization, bystander activity, and cytotoxicity for the same candidate.
- Cell lines expressing human, monkey, and mouse target antigens support cross-species assessment.
- Gene-edited target knockout cell lines allow wild-type and knockout responses to be compared.
Discuss Your ADC Testing Project
Share your target, candidate format, and study goals, and the Kyinno team will help identify which assays fit your ADC platform evaluation.